These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 31779517)

  • 1. A Survey of Provider Attitudes, Beliefs, and Perceived Barriers Regarding a Centralized Direct-Mail Colorectal Cancer Screening Approach at Community Health Centers.
    Thompson JH; Schneider JL; Rivelli JS; Petrik AF; Vollmer WM; Fuoco MJ; Coronado GD
    J Prim Care Community Health; 2019; 10():2150132719890950. PubMed ID: 31779517
    [No Abstract]   [Full Text] [Related]  

  • 2. An observational study of workflows to support fecal testing for colorectal cancer screening in primary care practices serving Medicaid enrollees.
    Mojica CM; Gunn R; Pham R; Miech EJ; Romer A; Renfro S; Clark KD; Davis MM
    BMC Cancer; 2022 Jan; 22(1):106. PubMed ID: 35078444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of a Mailed Colorectal Cancer Screening Outreach Program in Community Health Clinics: The STOP CRC Cluster Randomized Clinical Trial.
    Coronado GD; Petrik AF; Vollmer WM; Taplin SH; Keast EM; Fields S; Green BB
    JAMA Intern Med; 2018 Sep; 178(9):1174-1181. PubMed ID: 30083752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Applying the Plan-Do-Study-Act (PDSA) approach to a large pragmatic study involving safety net clinics.
    Coury J; Schneider JL; Rivelli JS; Petrik AF; Seibel E; D'Agostini B; Taplin SH; Green BB; Coronado GD
    BMC Health Serv Res; 2017 Jun; 17(1):411. PubMed ID: 28629348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strategies and Opportunities to STOP Colon Cancer in Priority Populations: design of a cluster-randomized pragmatic trial.
    Coronado GD; Vollmer WM; Petrik A; Taplin SH; Burdick TE; Meenan RT; Green BB
    Contemp Clin Trials; 2014 Jul; 38(2):344-9. PubMed ID: 24937017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors Influencing Implementation of a Colorectal Cancer Screening Improvement Program in Community Health Centers: an Applied Use of Configurational Comparative Methods.
    Petrik AF; Green B; Schneider J; Miech EJ; Coury J; Retecki S; Coronado GD
    J Gen Intern Med; 2020 Nov; 35(Suppl 2):815-822. PubMed ID: 33107003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Moderators of the effectiveness of an intervention to increase colorectal cancer screening through mailed fecal immunochemical test kits: results from a pragmatic randomized trial.
    O'Connor EA; Vollmer WM; Petrik AF; Green BB; Coronado GD
    Trials; 2020 Jan; 21(1):91. PubMed ID: 31941527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Colonoscopy Outreach vs Fecal Immunochemical Test Outreach on Colorectal Cancer Screening Completion: A Randomized Clinical Trial.
    Singal AG; Gupta S; Skinner CS; Ahn C; Santini NO; Agrawal D; Mayorga CA; Murphy C; Tiro JA; McCallister K; Sanders JM; Bishop WP; Loewen AC; Halm EA
    JAMA; 2017 Sep; 318(9):806-815. PubMed ID: 28873161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A cost-effectiveness analysis of a colorectal cancer screening program in safety net clinics.
    Meenan RT; Coronado GD; Petrik A; Green BB
    Prev Med; 2019 Mar; 120():119-125. PubMed ID: 30685318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implementation successes and challenges in participating in a pragmatic study to improve colon cancer screening: perspectives of health center leaders.
    Coronado GD; Schneider JL; Petrik A; Rivelli J; Taplin S; Green BB
    Transl Behav Med; 2017 Sep; 7(3):557-566. PubMed ID: 28150097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Barriers to Colorectal Cancer Screening in a Racially Diverse Population Served by a Safety-Net Clinic.
    Nagelhout E; Comarell K; Samadder NJ; Wu YP
    J Community Health; 2017 Aug; 42(4):791-796. PubMed ID: 28168395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Patient Portal Messaging Before Mailing Fecal Immunochemical Test Kit on Colorectal Cancer Screening Rates: A Randomized Clinical Trial.
    Goshgarian G; Sorourdi C; May FP; Vangala S; Meshkat S; Roh L; Han MA; Croymans DM
    JAMA Netw Open; 2022 Feb; 5(2):e2146863. PubMed ID: 35119462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outreach invitations for FIT and colonoscopy improve colorectal cancer screening rates: A randomized controlled trial in a safety-net health system.
    Singal AG; Gupta S; Tiro JA; Skinner CS; McCallister K; Sanders JM; Bishop WP; Agrawal D; Mayorga CA; Ahn C; Loewen AC; Santini NO; Halm EA
    Cancer; 2016 Feb; 122(3):456-63. PubMed ID: 26535565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative effectiveness of a multifaceted intervention to improve adherence to annual colorectal cancer screening in community health centers: a randomized clinical trial.
    Baker DW; Brown T; Buchanan DR; Weil J; Balsley K; Ranalli L; Lee JY; Cameron KA; Ferreira MR; Stephens Q; Goldman SN; Rademaker A; Wolf MS
    JAMA Intern Med; 2014 Aug; 174(8):1235-41. PubMed ID: 24934845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness and cost of multilayered colorectal cancer screening promotion interventions at federally qualified health centers in Washington State.
    Kemper KE; Glaze BL; Eastman CL; Waldron RC; Hoover S; Flagg T; Tangka FKL; Subramanian S
    Cancer; 2018 Nov; 124(21):4121-4129. PubMed ID: 30359468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association Between Primary Care Visits and Colorectal Cancer Screening Outcomes in the Era of Population Health Outreach.
    Halm EA; Beaber EF; McLerran D; Chubak J; Corley DA; Rutter CM; Doubeni CA; Haas JS; Balasubramanian BA
    J Gen Intern Med; 2016 Oct; 31(10):1190-7. PubMed ID: 27279097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient-Refined Messaging for a Mailed Colorectal Cancer Screening Program: Findings from the PROMPT Study.
    Coronado GD; Thompson JH; Petrik AF; Nyongesa DB; Leo MC; Castillo M; Younger B; Escaron A; Chen A
    J Am Board Fam Med; 2019; 32(3):318-328. PubMed ID: 31068396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mailed FIT (fecal immunochemical test), navigation or patient reminders? Using microsimulation to inform selection of interventions to increase colorectal cancer screening in Medicaid enrollees.
    Davis MM; Nambiar S; Mayorga ME; Sullivan E; Hicklin K; O'Leary MC; Dillon K; Hassmiller Lich K; Gu Y; Lind BK; Wheeler SB
    Prev Med; 2019 Dec; 129S():105836. PubMed ID: 31635848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct-to-member mailed colorectal cancer screening outreach for Medicaid and Medicare enrollees: Implementation and effectiveness outcomes from the BeneFIT study.
    Coronado GD; Green BB; West II; Schwartz MR; Coury JK; Vollmer WM; Shapiro JA; Petrik AF; Baldwin LM
    Cancer; 2020 Feb; 126(3):540-548. PubMed ID: 31658375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Persistent Barriers to Colorectal Cancer Screening Completion Amid Centralized Outreach: A Mixed Methods Study.
    Wainwright JV; Mehta SJ; Clifton A; Bocage C; Ogden SN; Cohen S; Rendle KA
    Am J Health Promot; 2022 May; 36(4):697-705. PubMed ID: 34970929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.